Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Herbert Patterson

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of the American College of Cardiology|July 21, 2018
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF RegistryStephen J Greene, Javed Butler, Nancy M Albert, et al.
JACC. Heart Failure|May 11, 2020
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF RegistryMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
The American Journal of Cardiology|November 5, 2019
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)Erika M Giblin, Kirkwood F Adams, Larry Hill, et al.
JACC. Heart Failure|September 16, 2019
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection FractionYevgeniy Khariton, Gregg C Fonarow, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|December 27, 2017
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysClyde W Yancy, James L Januzzi, Larry A Allen, et al.
JACC. Heart Failure|February 11, 2019
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF RegistryPoghni A Peri-Okonny, Xiaojuan Mi, Yevgeniy Khariton, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
JACC. Heart Failure|June 10, 2019
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HFMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|January 15, 2021
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee, Thomas M Maddox, James L Januzzi, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of the American College of Cardiology|July 21, 2018
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF RegistryStephen J Greene, Javed Butler, Nancy M Albert, et al.
JACC. Heart Failure|May 11, 2020
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF RegistryMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
The American Journal of Cardiology|November 5, 2019
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)Erika M Giblin, Kirkwood F Adams, Larry Hill, et al.
JACC. Heart Failure|September 16, 2019
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection FractionYevgeniy Khariton, Gregg C Fonarow, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|December 27, 2017
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysClyde W Yancy, James L Januzzi, Larry A Allen, et al.
JACC. Heart Failure|February 11, 2019
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF RegistryPoghni A Peri-Okonny, Xiaojuan Mi, Yevgeniy Khariton, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
JACC. Heart Failure|June 10, 2019
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HFMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|January 15, 2021
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee, Thomas M Maddox, James L Januzzi, et al.
Pageof 7